title: Safety and efficacy of a long-acting liposomal formulation of plasma-derived factor VIII in haemophilia A patients.
authors.forename: Jack
authors.initials: J
authors.lastname: Spira
authors.forename: Olga
authors.initials: O
authors.lastname: Plyushch
authors.forename: Tatiana
authors.initials: T
authors.lastname: Andreeva
authors.forename: Vladimir
authors.initials: V
authors.lastname: Zorenko
authors.forename: Nadezhda
authors.initials: N
authors.lastname: Zozulya
authors.forename: Irena
authors.initials: I
authors.lastname: Velichkoi
authors.forename: Olga Ervinovna
authors.initials: OE
authors.lastname: Zalepukhina
authors.forename: Rivka
authors.initials: R
authors.lastname: Yatuv
authors.forename: Moshe
authors.initials: M
authors.lastname: Baru
mesh_terms: D000328:Adult; D005169:Factor VIII / Q000008:administration & dosage* / Q000009:adverse effects; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D008081:Liposomes; D055815:Young Adult
chemical_list: D008081:Liposomes; D005169:Factor VIII